Halostestin Magnus Pharmaceuticals: Compound Profile
Halostestin Magnus Pharmaceuticals is a laboratory-grade fluoxymesterone preparation manufactured under pharmaceutical-grade conditions for analytical research purposes. Fluoxymesterone is a synthetic 17α-methylated androgenic-anabolic steroid compound with documented potent androgenic properties in laboratory models. This formulation represents Magnus Pharmaceuticals’ commitment to producing research-quality materials for scientific investigation. Researchers at Stroid UK Shop can access this compound alongside our comprehensive catalogue of research chemicals including SARMs and peptides for comparative molecular studies.
Laboratory Applications
Research scientists investigate fluoxymesterone in various analytical contexts including androgen receptor binding assays, hepatic metabolism studies, and comparative steroid pharmacology research. The compound’s unique molecular structure, featuring 17α-methylation and fluorine substitution, makes it valuable for examining structure-activity relationships in androgenic steroid research. Laboratory protocols often examine this compound’s interaction with hepatic enzymes, particularly focusing on its resistance to 3α-hydroxysteroid dehydrogenase activity. Researchers studying the fluoxymesterone category utilize this Magnus Pharmaceuticals preparation for analytical method development and validation studies.
Technical Specifications
| Chemical Name | 17β-Hydroxy-17α-methylandrost-4-en-3-one 9α-fluoro |
|---|---|
| CAS Number | 76-43-7 |
| Molecular Formula | C₂₀H₂₉FO₃ |
| Molecular Weight | 336.44 g/mol |
| Manufacturer | Magnus Pharmaceuticals |
| Storage Requirements | Room temperature, dry conditions, protect from light |
| Analytical Grade | Research laboratory standard |
Research Compliance
This fluoxymesterone preparation is manufactured exclusively for laboratory research applications and analytical studies. Halostestin Magnus Pharmaceuticals is not intended for human consumption, clinical use, or any application outside controlled research environments. Researchers must ensure appropriate laboratory safety protocols and comply with institutional guidelines for handling androgenic steroid compounds. All investigations should follow established analytical chemistry procedures and maintain proper documentation for research integrity.
